Daré Bioscience, Inc. (NASDAQ:DARE) Shares Purchased by AMH Equity Ltd

AMH Equity Ltd boosted its position in shares of Daré Bioscience, Inc. (NASDAQ:DARE) by 50.0% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 150,000 shares of the biotechnology company’s stock after acquiring an additional 50,000 shares during the quarter. AMH Equity Ltd’s holdings in Daré Bioscience were worth $468,000 as of its most recent filing with the Securities & Exchange Commission.

Daré Bioscience Stock Performance

Shares of NASDAQ:DARE opened at $3.18 on Thursday. Daré Bioscience, Inc. has a one year low of $2.67 and a one year high of $7.56. The stock has a market capitalization of $27.67 million, a price-to-earnings ratio of -5.38 and a beta of 1.32. The company has a 50-day simple moving average of $3.19 and a 200-day simple moving average of $3.38.

Analyst Ratings Changes

Separately, HC Wainwright restated a “buy” rating and set a $12.00 target price on shares of Daré Bioscience in a research report on Tuesday, December 17th.

About Daré Bioscience

Daré Bioscience, Inc, a biopharmaceutical company, identifies, develops, and markets products for women's health in the United States. It develops therapies in the areas of contraception, reproductive health, menopause, fertility, and sexual and vaginal health. The company offers XACIATO for the treatment of bacterial vaginosis in female patients 12 years of age and older.